首页> 外文OA文献 >A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries
【2h】

A phage display approach for rapid antibody humanization: Designed combinatorial V gene libraries

机译:快速抗体人源化的噬菌体展示方法:设计的组合V基因库

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

The development of a new strategy for antibody humanization is described. This strategy incorporates key recognition sequences from the parental rodent antibody into a phage display-based selection strategy. The original sequences of the third complementarity-determining regions (CDRs) of heavy and light chains, HCDR3 and LCDR3, were maintained and all other sequences were replaced by human sequences selected from phage-displayed antibody libraries. This approach was applied to the humanization of mouse mAb LM609 that is directed to human integrin αvβ3 and has potential applicability in cancer therapy as an antiangiogenic agent. We demonstrate this approach (i) provides a rapid route for antibody humanization constraining the content of original mouse sequences in the final antibodies to the most hypervariable of the CDRs; (ii) generates several humanized versions with different sequences at the same time; (iii) results in affinities as high as or higher than the affinity of the original antibody; and (iv) retains the antigen and epitope specificity of the original antibody. The production of multiple humanized variants may present advantages in the selection of antibodies that are more readily expressed on a large scale and could be important in therapeutic regimens that call for long-term treatment with antibodies in which antiidiotypic responses might be avoided by administration of alternative antibodies.
机译:描述了抗体人源化的新策略的发展。该策略将来自亲本啮齿动物抗体的关键识别序列整合到基于噬菌体展示的选择策略中。重链和轻链的第三个互补决定区(CDR)的原始序列HCDR3和LCDR3得以保留,所有其他序列都被选自噬菌体展示抗体库的人源序列取代。该方法已应用于针对人整联蛋白αvβ3的小鼠mAb LM609的人源化,在作为抗血管生成剂的癌症治疗中具有潜在的适用性。我们证明了这种方法(i)为抗体人源化提供了一条快速途径,可以将最终抗体中原始小鼠序列的内容限制在CDR的最高可变性上; (ii)同时生成多个具有不同序列的人性化版本; (iii)导致亲和力高于或高于原始抗体的亲和力; (iv)保留原始抗体的抗原和表位特异性。多种人源化变体的产生可能在选择更易于大规模表达的抗体时表现出优势,并且在需要长期治疗抗体的治疗方案中可能是重要的,在该治疗方案中,通过施用替代抗体可以避免抗独特型反应抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号